Find and Pitch Jounalists, Get Your Story Covered

Tags: Palazestrant Phase 1b/2 Trial Future Trials

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug - 7 days ago FDA Approves First Phosphate Absorption Inhibitor for CKD - about 1 year ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pegfilgrastim-Fpgk Shows Structural, Functional Biosimilarity to Reference Product - 9 days ago FDA Grants Orphan Drug Designation to PPL-002 for the Treatment of Danon Disease - about 1 month ago Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 2 months ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 3 months ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - 3 months ago FDA Approves Palopegteriparatide for Treatment of Hypoparathyroidism - 3 months ago FDA Grants Orphan Drug Designation to ZMA001 for Pulmonary Arterial Hypertension - 3 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 8 months ago AstraZeneca to Initiate Trial for Triple-Combination Inhaled Therapy for Chronic Obstructive Pulmonary Disease - 8 months ago FDA Approves Berdazimer Topical Gel as First Treatment for Molluscum Contagiosum - 10 months ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - 11 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs - 12 months ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - 12 months ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - about 1 year ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - about 1 year ago FDA Grants Priority Review to New Drug Application for Belzutifan for Advanced Renal Cell Carcinoma - about 1 year ago
3	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy - 19 days ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 7 months ago Novel Chemotherapy Method Could Decrease Lung Cancer Tumor Size - 9 months ago FDA Approves Pembrolizumab Plus Chemotherapy to Treat Metastatic HER2-Negative Gastric, Gastroesophageal Junction Adenocarcinoma - 12 months ago
4	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Long-Term Data Support Non-Hormonal Drug for Hot-Flash Management - about 2 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - about 2 months ago Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma - 2 months ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 3 months ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - 9 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - 10 months ago Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC - 11 months ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - 12 months ago Pembrolizumab in First-Line Boosts PFS in HER2-Positive Stomach Cancer - about 1 year ago
6	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome - 2 months ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies - 10 months ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Treatments - 11 months ago FDA Approves Zilucoplan for Generalized Myasthenia Gravis in AChR Antibody-Positive Adults - about 1 year ago
7	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 3 months ago
8	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic HER2-Positive Solid Tumors - 7 months ago FDA Approves Tislelizumab-jsgr for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy - 8 months ago
9	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer - 8 months ago FDA Approves Expanded Indications for Spesolimab-sbzo Injection for the Treatment of Generalized Pustular Psoriasis - 8 months ago Risankizumab Demonstrated Superior to Apremilast for Patients With Moderate Psoriasis - 8 months ago
10	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication - 8 months ago Drug-Coated Balloon Answers 'Embarrassing' Need for In-Stent Restenosis in U.S. - about 1 year ago

Journalists covering Palazestrant